Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis

Archives of Dermatology

Volumn 148, Issue 12, 2012, Pages 1423-1425

  Viguier, Manuelle ^a,g   Aubin, François ^b,g   Delaporte, Emmanuel ^c   Pagès, Cécile ^a   Paul, Carle ^d,g   Beylot Barry, Marie ^e,g   Goujon, Catherine ^f,g   Rybojad, Michel ^a   Bachelez, Hervé ^a,g,h  

^a Universite de Paris Diderot   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c UNIV LILLE   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

^g Groupe de Recherche sur le Psoriasis GrPso de la Société Française de Dermatologie   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ACUTE DISEASE; ADVERSE OUTCOME; ARTICLE; BLEPHARITIS; BREAST CANCER; CLINICAL ARTICLE; CLINICAL EVALUATION; CONJUNCTIVITIS; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HEPATITIS; HERPETIC WHITLOW; HUMAN; HYPERSENSITIVITY; LUPUS VULGARIS; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PUSTULAR PSORIASIS; REMISSION; RETROSPECTIVE STUDY; SKIN ABSCESS; TREATMENT DURATION; TREATMENT FAILURE; URTICARIA; VOMITING;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871385821     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/2013.jamadermatol.80     Document Type: Article

References (5)

1. Esposito M, Mazzotta A, Casciello C, Chimenti S. Etanercept at different dosages in the treatment of generalized pustular psoriasis: a case series. Dermatology. 2008;216(4):355-360. (Pubitemid 351630104)
2. Trent JT, Kerdel FA. Successful treatment of Von Zumbusch pustular psoriasis with infliximab. J Cutan Med Surg. 2004;8(4):224-228. (Pubitemid 41226447)
3. Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res. 2003;295(suppl 1):S43-S54.
4. Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620-628.
5. Smith CH, Anstey AV, Barker JN, et al Chair of Guideline Group. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009;161(5):987-1019.